Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus.

Autor: Yang J; School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Yan Y; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Dai Q; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Yin J; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Zhao L; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Li Y; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Li W; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Zhong W; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China., Cao R; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. Electronic address: 21cc@163.com., Li S; School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. Electronic address: lis.lisong@gmail.com.
Jazyk: angličtina
Zdroj: Virologica Sinica [Virol Sin] 2022 Feb; Vol. 37 (1), pp. 145-148. Date of Electronic Publication: 2022 Jan 18.
DOI: 10.1016/j.virs.2022.01.014
Databáze: MEDLINE